The case of University of Toronto clinician, Dr. Nancy Olivieri, gained attention when her research at the Hospital for Sick Children led her to believe that a new drug treatment posed dangers to some patients. It is alleged that the hospital and the university failed to come to her defence when Apotex, co-sponsor of the research, objected to her publishing her findings. It is further alleged that hospital and university officials and representatives of Apotex variously subjected her to workplace and other harassment.
The case was reviewed by CAUT’s Committee on Academic Freedom and Tenure which concluded that the issues raised are serious and that many questions remain unanswered by reviews conducted by other bodies. In addition to matters affecting Dr. Olivieri, broad institutional policy issues exist. Accordingly, the AF&T committee has appointed an independent committee of inquiry.
Resources